创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

苗玉清, 张欢, 彭明丽, 樊海明. 准顺磁超小铁氧体纳米对比剂的磁共振成像应用研究进展[J]. 药学进展, 2021, 45(4): 283-289.
引用本文: 苗玉清, 张欢, 彭明丽, 樊海明. 准顺磁超小铁氧体纳米对比剂的磁共振成像应用研究进展[J]. 药学进展, 2021, 45(4): 283-289.
MIAO Yuqing, ZHANG Huan, PENG Mingli, FAN Haiming. Advances of Research on Quasi-paramagnetic Ultrasmall Ferrite Contrast Agents for Magnetic Resonance Imaging[J]. Progress in Pharmaceutical Sciences, 2021, 45(4): 283-289.
Citation: MIAO Yuqing, ZHANG Huan, PENG Mingli, FAN Haiming. Advances of Research on Quasi-paramagnetic Ultrasmall Ferrite Contrast Agents for Magnetic Resonance Imaging[J]. Progress in Pharmaceutical Sciences, 2021, 45(4): 283-289.

准顺磁超小铁氧体纳米对比剂的磁共振成像应用研究进展

Advances of Research on Quasi-paramagnetic Ultrasmall Ferrite Contrast Agents for Magnetic Resonance Imaging

  • 摘要: 受益于独特的磁学性质和较高的生物学相容性,铁氧体纳米材料作为影像对比剂在磁共振成像临床诊断和影像学研究中获得了广泛应用。特别是尺寸小于5 nm的准顺磁超小铁氧体纳米颗粒,具有高T1信号增强以及快速的肾清除能力,有望克服现有临床钆基T1对比剂在灵敏度和安全性方面的不足,发展成为下一代先进磁共振对比剂。从准顺磁超小铁氧体纳米对比剂的安全性、T1-T2信号增强特性、多模态成像及诊疗一体化应用等方面,综述近年来其在磁共振分子影像领域的研究进展及临床转化面临的挑战。

     

    Abstract: Benefiting from their unique magnetic properties and good biosafety, ferrite nanomaterials are widely used in magnetic resonance imaging (MRI) clinical diagnostics and imaging studies. Quasi-paramagnetic ultrasmall ferrite nanoparticles with the size of less than 5 nm possess high T1 contrast power and rapid renal clearance, which can help to overcome the drawbacks of traditional gadolinium-based contrast agents with improved safety and efficacy, and are likely to become the next-generation MRI contrast agents. This review summarizes the research progress and challenges of clinical translation of quasi-paramagnetic ferrite nanoprobes as MRI T1 contrast agents in terms of safety, T1-T2 signal enhancement properties, multimodal imaging and integration of diagnosis and treatment.

     

/

返回文章
返回